comparemela.com
Home
Live Updates
Marie Thibault - Breaking News
Pages:
28
29
30
31
32
33
34
Latest Breaking News On - Marie thibault - Page 27 : comparemela.com
Analysts high on AtriCure following AFib procedure update
Analysts have a positive outlook on AtriCure following an investor webinar discussing the company's Convergent procedure.
District of columbia
United states
Mike matson
Eric buch
Zayd eldadah
Marie thibault
Medstar heart vascular institute
Medstar heart
Vascular institute
Data backs Boston Scientific Sentinel cerebral protection system
Boston Scientific announced that its PROTECTED TAVR clinical trial evaluating its Sentinel system missed its primary endpoint.
United states
United kingdom
Ian meredith
Samir kapadia
Marie thibault
Vascular thoracic institute
Boston scientific
Suzanne tomsich department of cardiovascular medicine
Massachusetts based boston scientific
Transcatheter cardiovascular therapeutics
New england journal
Suzanne tomsich department
Cardiovascular medicine
Arnold miller family heart
Thoracic institute
Edwards TEER therapy proves safe and effective
Edwards Lifesciences announced data confirming its transcatheter edge-to-edge repair (TEER) as safe and effective.
Edward pascal
Edwards pascal
Bernardj zovighian
Marie thibault
Abbott mitraclip
University of virginia health system
Heart valve center
Edwards lifesciences
Transcatheter cardiovascular therapeutics
Scott lim
Advanced heart valve center
Virginia health system
4 major cardiology trends you need to know from TCT 2022
Medtronic, Edwards and Abbott presented positive data at TCT as TAVR, TEER and renal denervation innovations continue to arrive.
United states
Michael dale
Ian meredith
Symplicity spyral
Marie thibault
Nina goodheart
American heart association scientific sessions
Boston scientific
Transcatheter cardiovascular therapeutics
Cor medical
Recor medical
Edwards lifesciences
Pathological study
Hypo attenuated leaflet thickening
Structural heart
Amplatzer amulet
Analysts see multi-year transition to growth for Embecta
Embecta (Nasdaq:EMBC), the BD diabetes business spinoff, may take a few years to move into a growth phase, analysts say.
Sam eiber
Marie thibault
vimarsana © 2020. All Rights Reserved.